THE HAIN CELESTIALOctober 20, 2023

FDA 483 - THE HAIN CELESTIAL - October 20, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore THE HAIN CELESTIAL

Record Details

THE HAIN CELESTIAL, a drug product manufacturer in Bell, CA, was inspected by the FDA from October 17-20, 2023. The inspection revealed a failure to thoroughly review and investigate out-of-specification viscosity stability for several OTC drug products. Additionally, the firm lacked established control procedures and process validation for various OTC drug products, indicating deficiencies in quality control and manufacturing process oversight.

Company: THE HAIN CELESTIAL
Inspection Date: October 20, 2023
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
People: Lillian S. Wu
Tiara M. Brown (Consumer Safety Officer)

Open in Dashboard

ID · f252e7bb-4f1c-4e33-b63f-f92c56baf5f1